Paragraph 5
The legal representative may, without F1the participant being subject to any resulting detriment, withdraw the participant from the trial at any time by revoking his informed consent.
Annotations
Textual amendments
- F1
Words in Sch. 1 Pt. 5 substituted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 37(6)(a)
Notes on Schedule 1
Textual amendments
- F1
Word in Sch. 1 heading substituted (28.4.2026) by The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2025 (S.I. 2025/538), regs. 1(2), 37(2)